Final results from PAVES, a phase 3, randomized, double-blind, placebo-controlled trial of pegfilgrastim in patients (pts) receiving first-line FOLFOX or FOLFIRI and bevacizumab for locally advanced or metastatic colorectal cancer (LA/mCRC) (NCT00911170)

Please use this identifier to cite or link to this item: https://dspace.uzhnu.edu.ua/jspui/handle/lib/10576

Title:	Final results from PAVES, a phase 3, randomized, double-blind, placebo-controlled trial of pegfilgrastim in patients (pts) receiving first-line FOLFOX or FOLFIRI and bevacizumab for locally advanced or metastatic colorectal cancer (LA/mCRC) (NCT00911170)
Authors:	T. Pinter P.K. Morrow A. Cesas A. Croitoru J. Decaestecker P. Gibbs Y. Hotko J. Jassem G. Kurteva J. Novotny S. O'Reilly T. Salek L. Khosrowshahi M. Reiner Z. Klippel C. Blanke
Issue Date:	2015
Type:	Text
Publication type:	Стаття
URI:	https://dspace.uzhnu.edu.ua/jspui/handle/lib/10576
Appears in Collections:	Наукові публікації кафедри радіології та онкології

Files in This Item:

File	Description	Size	Format
main.pdf.png		214.81 kB	image/png	View/Open